Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alternative Dosing of Palbociclib in Metastatic HR+ Breast Cancer
NCT03007979Phase 2Completed
- Sponsor
- Washington University School of Medicine
- Start
- Jun 2017
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of palbociclib in breast cancer, sponsored by Washington University School of Medicine. Started Jun 2017; status: completed.
02
Drugs
palbociclib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT03007979.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03007979.